We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+8.26%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$2.55B
AUM Growth
+$25.8M
Cap. Flow
-$138M
Cap. Flow %
-5.42%
Top 10 Hldgs %
14.48%
Holding
1,057
New
159
Increased
342
Reduced
417
Closed
139

Top Buys

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$21.6M
2
ILMN icon
Illumina
ILMN
+$19.5M
3
IPGP icon
IPG Photonics
IPGP
+$12.3M
4
NVDA icon
NVIDIA
NVDA
+$11.2M
5
KDP icon
Keurig Dr Pepper
KDP
+$7.63M

Sector Composition

Rank Sector Weight
1 Technology 27.48%
2 Industrials 12.8%
3 Healthcare 12.25%
4 Consumer Discretionary 9.24%
5 Financials 5.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RA
76
Brookfield Real Assets Income Fund
RA
$708M
$4.98M 0.19%
215,900
+8,045
+4% +$187K
EVR icon
77
Evercore
EVR
$11.8B
$4.91M 0.19%
48,868
-317
-0.6% -$34.2K
HCA icon
78
HCA Healthcare
HCA
$89.5B
$4.82M 0.19%
34,655
-13,073
-27% -$1.63M
MOH icon
79
Molina Healthcare
MOH
$10.3B
$4.81M 0.19%
32,358
-5,872
-15% -$750K
UFS
80
DELISTED
DOMTAR CORPORATION (New)
UFS
$4.81M 0.19%
92,248
+12,776
+16% +$643K
CEM
81
DELISTED
ClearBridge MLP and Midstream Fund Inc.
CEM
$4.79M 0.19%
65,875
+2,695
+4% +$198K
TGT icon
82
Target
TGT
$68B
$4.78M 0.19%
+54,239
New +$4.51M
UNH icon
83
UnitedHealth
UNH
$370B
$4.75M 0.19%
17,852
-1,679
-9% -$437K
UGI icon
84
UGI
UGI
$7.33B
$4.74M 0.19%
85,493
+72,498
+558% +$3.91M
IDCC icon
85
InterDigital
IDCC
$8.89B
$4.68M 0.18%
58,523
-11,787
-17% -$966K
BBY icon
86
Best Buy
BBY
$17.3B
$4.68M 0.18%
58,971
-7,744
-12% -$600K
CVS icon
87
CVS Health
CVS
$122B
$4.67M 0.18%
59,333
+1,290
+2% +$92.2K
DBI icon
88
Designer Brands
DBI
$333M
$4.66M 0.18%
137,529
-49,151
-26% -$1.44M
MC icon
89
Moelis & Co
MC
$4.94B
$4.63M 0.18%
84,439
+23,165
+38% +$1.36M
WBA
90
DELISTED
Walgreens Boots Alliance
WBA
$4.54M 0.18%
62,218
+50,566
+434% +$3.43M
TSN icon
91
Tyson Foods
TSN
$20.4B
$4.48M 0.18%
75,207
+7,531
+11% +$471K
PGR icon
92
Progressive
PGR
$125B
$4.44M 0.17%
62,562
-12,570
-17% -$809K
ELV icon
93
Elevance Health
ELV
$85.5B
$4.41M 0.17%
16,078
-994
-6% -$258K
MKSI icon
94
MKS Inc
MKSI
$20.6B
$4.37M 0.17%
54,457
+20,484
+60% +$1.87M
LDOS icon
95
Leidos
LDOS
$17.3B
$4.35M 0.17%
62,944
+57,322
+1,020% +$3.89M
BMY icon
96
Bristol-Myers Squibb
BMY
$132B
$4.34M 0.17%
69,872
-2,459
-3% -$146K
UAL icon
97
United Airlines
UAL
$42.1B
$4.33M 0.17%
48,629
-6,871
-12% -$567K
BC icon
98
Brunswick
BC
$5.28B
$4.3M 0.17%
64,141
+51,261
+398% +$3.39M
HPQ icon
99
HP
HPQ
$27.5B
$4.29M 0.17%
166,609
+6,276
+4% +$152K
WDR
100
DELISTED
Waddell & Reed Financial, Inc.
WDR
$4.28M 0.17%
201,860
+11,809
+6% +$237K

Similar funds

Vident Investment Advisory's Q3 2018 Portfolio in Review

As of Q3 2018, Vident Investment Advisory held 1,057 positions worth $2.55B, up 1% from $2.53B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Vident Investment Advisory withdrew a net $138M in Q3 2018, closing 139 positions and reducing 417 holdings. Its most notable exit was Boston Beer, an estimated $5.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Vident Investment Advisory opened a new position in Aptiv worth $19.9M.

  • Vident Investment Advisory's largest Q3 2018 buy was Aptiv: 236,834 shares worth $19.9M.
  • Vident Investment Advisory added most to Illumina in Q3 2018, an estimated $19.5M increase.
  • Vident Investment Advisory's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $36.9M.
  • Vident Investment Advisory fully exited Boston Beer in Q3 2018, selling an estimated $5.6M.
  • Vident Investment Advisory's ten largest holdings make up 14% of its $2.55B portfolio in Q3 2018.
  • Vident Investment Advisory opened 159 new positions and closed 139 in Q3 2018.
  • Vident Investment Advisory's portfolio value rose 1% quarter-over-quarter to $2.55B.

Based on Vident Investment Advisory's 13F filing for Q3 2018, filed 14 Nov 2018.